• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·INDRANIB.BO
Share

Indrayani Biotech Limited Stocks

₹ 8.68Last Updated 21.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 3.91M

₹ 8.68
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Indrayani Biotech Ltd. conducts its business across a wide array of sectors, including Food and Hospitality, Dairy, Healthcare and Pharmaceuticals, Engineering, Biotechnology, Agriculture, and Infrastructure. The company organizes its operations into three primary reporting segments: Foods and Hospitality, Engineering, and Healthcare. This entity was established on March 9, 1992, and its main office is located in Chennai, India.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.10.2026 15:25

Morning in New York: Tech Giants Wake Up the "Bears"

22.10.2026 15:05

Hermès has been hit by a decline in demand in China. What should investors do with their shares after a 40% drop?

22.10.2026 14:48

Brent surged to its highest level since May. The NYT reported that the U.S. is preparing strikes against Iran

22.10.2026 14:02

eBay shares rose following the announcement of a 9% workforce reduction. Should you buy these stocks?

22.10.2026 13:20

The Euro vs. the Barricades: What Affects Its Exchange Rate More Than the Crisis in France

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026